Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Volumn 19, Issue 1, 2008, Pages 115-122

  Kosmidis, P A ^a   Kalofonos, H P ^a   Christodoulou, C ^a   Syrigos, K ^a   Makatsoris, T ^a   Skarlos, D ^a   Bakogiannis, C ^a   Nicolaides, C ^a   Bafaloukos, D ^a   Bamias, A ^a   Samantas, E ^a   Xiros, N ^a   Boukovinas, I ^a   Fountzilas, G ^a   Dimopoulos, M A ^a  

^a HYGEIA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CIMETIDINE; DEOXYCYTIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; DRUG DERIVATIVE; GEMCITABINE; ONDANSETRON; PACLITAXEL;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PREMEDICATION; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; TOXIC HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CIMETIDINE; DEOXYCYTIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; FEMALE; HEART DISEASES; HEMATOLOGIC DISEASES; HEPATITIS, TOXIC; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONDANSETRON; PACLITAXEL; PREMEDICATION; PROPORTIONAL HAZARDS MODELS;

MLCS; MLOWN;

EID: 39049111157     PISSN: None     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm430     Document Type: Article

References (0)